InvestorsHub Logo

H2R

Followers 42
Posts 2159
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: midastouch017 post# 769

Tuesday, 05/16/2017 5:55:41 PM

Tuesday, May 16, 2017 5:55:41 PM

Post# of 3878
BEKINDA Q2 Top-line Phase III results (gastroenteritis)

Thanks MidasTouch!

I went back to the IR part of the RDHL site and they have a May 4th presentation reiterating the catalysts, including this Q2 gem :) They have had this Q2 catalyst confirmed over time. June 30th is not that far away!

http://files.shareholder.com/downloads/AMDA-1C0OBF/4198042611x0x941148/C7B9EC73-D8F6-4DC4-82D0-4700C1379538/RedHill_Biopharma_Corporate_Presentation_030517_.pdf

Best of luck!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News